Robert J Perez's Net Worth

$17 Million

Estimate Recalculated Nov 8, 2024 09:41PM EST

Who is Robert J Perez

Robert J Perez has an estimated net worth of $17 Million. This is based on reported shares across multiple companies, which include Unum Therapeutics Inc., Vir Biotechnology, Inc., Spark Therapeutics, Inc., ZAFGEN, INC., Cidara Therapeutics, Inc., AMAG PHARMACEUTICALS INC., Flex Pharma, Inc., CUBIST PHARMACEUTICALS INC, Third Harmonic Bio, Inc., EPIX Pharmaceuticals, Inc., and Immunocore Holdings plc.

SEC CIK

Robert J Perez's CIK is 0001263230

Past Insider Trading and Trends

2014 was Robert J Perez's most active year for acquiring shares with 19 total transactions. Robert J Perez's most active month to acquire stocks was the month of April. 2015 was Robert J Perez's most active year for disposing of shares, totalling 22 transactions. Robert J Perez's most active month to dispose stocks was the month of December. 2012 saw Robert J Perez paying a total of $4,984,501.22 for 245,450 shares, this is the most they've acquired in one year. In 2015 Robert J Perez cashed out on 735,330 shares for a total of $4,827,150.00, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Unum Therapeutics Inc.

Investor

Updated Jun 18, 2019

View Quote Details


Form 4	—	7.13K	$1.67	$11.88K	Jun 18, 2019	7.13K	Grant	—	Jun 14
Form 4	—	4.37K	$2.72	$11.88K	Apr 03, 2019	4.37K	Grant	—	Apr 01
Form 4	—	4.40K	$2.70	$11.87K	Jan 04, 2019	4.40K	Grant	—	Jan 02
Form 4	—	1.91K	$6.22	$11.88K	Oct 03, 2018	1.91K	Grant	—	Oct 01
Form 4	—	1.36K	$8.72	$11.87K	Sep 26, 2018	1.36K	Grant	—	Jul 26
Form 3	—	—	—	—	Mar 28, 2018	—	—	—	—

Showing 6 results

Vir Biotechnology, Inc.

Investor

Updated May 24, 2023

View Quote Details


Form 4	184.90%	18.08K	—	—	May 24, 2023	27.86K	Grant	—	May 22
Form 4	569.50%	19.21K	—	—	May 25, 2022	22.59K	Grant	—	May 23
Form 4	—	10.12K	—	—	May 25, 2021	10.12K	Grant	—	May 21
Form 4/A	—	24.57K	—	—	Oct 13, 2020	24.57K	Grant	—	May 21
Form 4	—	28.89K	—	—	May 26, 2020	28.89K	Grant	—	May 21
Form 3	—	—	—	—	Oct 10, 2019	—	—	—	—
Form 4	—	22.22K	—	—	Oct 10, 2019	22.22K	Grant	—	Oct 10

Showing 7 results

Spark Therapeutics, Inc.

Investor

Updated Dec 17, 2019


Form 4	-100.00%	-16.50K	$114.50	-$286.25K	Dec 17, 2019	—	Disposition	—	Dec 17
Form 4	—	—	—	—	Jun 03, 2019	2.50K	Options	—	May 30
Form 4	—	—	—	—	Jan 04, 2019	3.00K	Options	—	Jan 03
Form 4	—	5.50K	—	—	Jun 01, 2018	5.50K	Grant	—	May 30
Form 4	—	11.00K	—	—	Jan 04, 2018	11.00K	Grant	—	Jan 03
Form 3	—	—	—	—	Jan 04, 2018	—	—	—	—

Showing 6 results

ZAFGEN, INC.

Investor

Updated Jun 27, 2019

View Quote Details


Form 4	—	27.00K	—	—	Jun 27, 2019	27.00K	Grant	—	Jun 26
Form 4	1,127.92%	10.14K	$4.38	$19.37K	Jan 28, 2019	16.60K	Grant	—	Jan 24
Form 4	—	20.00K	—	—	Jun 07, 2018	20.00K	Grant	—	Jun 06
Form 4	—	9.42K	—	—	Jan 05, 2018	9.42K	Grant	—	Jan 03
Form 4	—	14.50K	—	—	Jun 23, 2017	14.50K	Grant	—	Jun 21
Form 4	—	13.29K	—	—	Feb 14, 2017	13.29K	Grant	—	Feb 13
Form 4	—	12.00K	—	—	Jul 01, 2016	12.00K	Grant	—	Jun 30
Form 4	—	5.56K	$6.29	$35.00K	Apr 12, 2016	6.46K	Grant	—	Jan 07
Form 4	—	899.00	$10.45	$9.39K	Oct 30, 2015	899.00	Grant	—	Oct 28
Form 4	—	24.00K	—	—	Sep 28, 2015	24.00K	Grant	—	Sep 24
Form 3	—	—	—	—	Sep 28, 2015	—	—	—	—

Showing 11 results

Cidara Therapeutics, Inc.

Investor

Updated Jun 26, 2017

View Quote Details


Form 4	—	11.00K	—	—	Jun 26, 2017	11.00K	Grant	—	Jun 22
Form 4	—	9.00K	—	—	Jul 18, 2016	9.00K	Grant	—	Jun 22
Form 4	—	9.00K	—	—	Jun 11, 2015	9.00K	Grant	—	Jun 09
Form 4	—	5.00K	$16.00	$80.00K	Apr 21, 2015	5.00K	Purchase	—	Apr 20
Form 3	—	—	—	—	Apr 14, 2015	—	—	—	—

Showing 5 results

AMAG PHARMACEUTICALS INC.

Investor

Updated May 20, 2019


Form 4	120.50%	25.44K	—	—	May 20, 2019	50.96K	Grant	—	May 16
Form 4	63.42%	11.12K	—	—	Jun 08, 2018	33.06K	Grant	—	Jun 07
Form 4	112.82%	14.65K	—	—	May 22, 2017	32.05K	Grant	—	May 18
Form 4	213.51%	17.55K	—	—	May 23, 2016	30.18K	Grant	—	May 19
Form 4	70.97%	4.90K	—	—	May 26, 2015	16.20K	Grant	—	May 21
Form 4	38.00%	1.90K	—	—	Aug 21, 2014	11.30K	Grant	—	May 27
Form 4	93.85%	6.10K	—	—	May 27, 2014	15.10K	Grant	—	May 22
Form 4	-27.78%	-2.50K	—	—	Apr 16, 2014	9.00K	Grant	—	Jun 13
Form 4	91.04%	6.10K	—	—	May 24, 2013	12.80K	Grant	—	May 23
Form 4/A	—	6.10K	—	—	May 25, 2012	6.10K	Grant	—	May 23
Form 4	—	5.70K	—	—	May 25, 2012	5.70K	Grant	—	May 23
Form 4	—	5.70K	—	—	May 25, 2011	5.70K	Grant	—	May 24
Form 4	—	7.50K	—	—	May 27, 2010	7.50K	Grant	—	May 25
Form 4	—	10.00K	—	—	Feb 26, 2009	10.00K	Grant	—	Feb 25
Form 3/A	—	—	—	—	Jan 30, 2009	—	—	—	—
Form 3	—	—	—	—	Jan 26, 2009	—	—	—	—

Showing 16 results

Flex Pharma, Inc.

Investor

Updated Jul 27, 2017

View Quote Details


Form 4	—	12.00K	—	—	Jul 27, 2017	12.00K	Grant	—	Jul 26
Form 3	—	—	—	—	Sep 09, 2015	—	—	—	—

Showing 2 results

CUBIST PHARMACEUTICALS INC

Chief Executive Officer

Updated Jan 21, 2015


Form 4	-100.00%	-740.34K	$102.00	-$5.34M	Jan 21, 2015	—	Disposition	—	Jan 21
Form 4	20.84%	12.45K	$59.96	$1.92K	Jan 05, 2015	77.21K	Acquisition	—	Dec 31 - Jan 01
Form 4	-1.91%	-1.00K	$63.68	-$63.87K	Aug 18, 2014	56.59K	Sale	—	Aug 15 - Aug 18
Form 4	0.73%	334.00	$57.87	$19.33K	Jul 02, 2014	51.22K	Acquisition	—	Jun 30
Form 4	—	24.84K	—	—	Jun 05, 2014	24.84K	Grant	—	Jun 03
Form 4	-3.20%	-1.52K	$67.50	-$102.46K	May 15, 2014	50.88K	Sale	—	May 14 - May 15
Form 4	-4.65%	-2.40K	$69.00	-$165.60K	May 14, 2014	54.27K	Sale	—	May 13 - May 14
Form 4	4.44%	213.00	$73.15	$15.58K	Apr 02, 2014	46.67K	Acquisition	—	Mar 31
Form 4	-41.86%	-30.00K	$49.85	-$1.82M	Feb 28, 2014	46.46K	Sale	—	Feb 27
Form 4	111.48%	70.04K	$75.00	-$262.80K	Feb 19, 2014	137.67K	Sell-Options	—	Feb 14 - Feb 18
Form 4	-21.00%	-10.00K	$48.55	-$528.10K	Jan 15, 2014	42.41K	Sale	—	Jan 15
Form 4	-17.36%	-10.00K	$47.55	-$508.10K	Jan 14, 2014	52.41K	Sale	—	Jan 13
Form 4	0.20%	76.00	$42.59	$3.24K	Jan 02, 2014	42.41K	Acquisition	—	Dec 31
Form 4	-51.59%	-40.00K	$45.48	-$1.91M	Nov 27, 2013	42.34K	Sale	—	Nov 25
Form 4	-2.28%	-1.02K	$60.55	-$62.00K	Aug 16, 2013	48.71K	Sale	—	Aug 15 - Aug 16
Form 4	1.36%	490.00	$36.69	$17.98K	Jul 02, 2013	41.23K	Acquisition	—	Jun 28
Form 4	-29.44%	-15.00K	$30.17	-$594.45K	May 22, 2013	40.74K	Sale	—	May 20
Form 4	-4.01%	-1.50K	$47.88	-$71.81K	May 17, 2013	40.74K	Sale	—	May 15 - May 16
Form 4	-3.83%	-1.49K	$48.41	-$72.14K	May 16, 2013	42.24K	Sale	—	May 14 - May 15
Form 4	-5.21%	-2.35K	$49.18	-$115.37K	May 15, 2013	47.48K	Sale	—	May 13 - May 14
Form 4	-22.60%	-14.67K	$38.28	-$549.19K	Apr 02, 2013	50.25K	Sale	—	Mar 28 - Apr 02
Form 4	171.22%	80.83K	$41.40	-$90.13K	Feb 20, 2013	132.93K	Sell-Options	—	Feb 15 - Feb 19
Form 4	0.63%	170.00	$33.12	$5.63K	Jan 03, 2013	32.10K	Acquisition	—	Dec 31
Form 4	-52.60%	-30.00K	$28.42	-$1.05M	Aug 27, 2012	31.93K	Sale	—	Aug 24
Form 4	1.75%	470.00	$32.22	$15.15K	Jul 03, 2012	31.93K	Acquisition	—	Jun 29
Form 4	-7.05%	-2.63K	$41.88	-$109.92K	May 16, 2012	34.59K	Sale	—	May 14 - May 16
Form 4	-4.74%	-2.13K	$41.55	-$88.55K	May 15, 2012	42.84K	Sale	—	May 13 - May 14
Form 4	1.05%	260.00	$43.25	$11.25K	Apr 03, 2012	24.97K	Acquisition	—	Mar 30
Form 4	-61.82%	-40.00K	$44.73	-$1.79M	Mar 28, 2012	24.71K	Sale	—	Mar 26
Form 4	—	120.00K	$42.09	$4.21M	Feb 21, 2012	120.00K	Grant	—	Feb 16
Form 4	-40.50%	-17.10K	$27.61	-$491.11K	Jan 17, 2012	25.13K	Sale	—	Jan 12 - Jan 13
Form 4	-25.66%	-14.40K	$27.12	-$399.39K	Jan 11, 2012	41.73K	Sale	—	Jan 10
Form 4	0.93%	232.00	$30.80	$7.15K	Jan 04, 2012	25.13K	Acquisition	—	Dec 30
Form 4	-30.91%	-25.00K	$26.37	-$655.81K	Dec 21, 2011	55.89K	Sale	—	Dec 20
Form 4	3.14%	758.00	$18.60	$14.10K	Jul 05, 2011	24.89K	Acquisition	—	Jun 30
Form 4	394.93%	120.00K	—	—	May 17, 2011	150.39K	Options	—	May 13 - May 15
Form 4	2.50%	437.00	$25.24	$11.03K	Apr 04, 2011	17.89K	Acquisition	—	Mar 31
Form 4	2.61%	444.00	$17.36	$7.71K	Jan 03, 2011	17.45K	Acquisition	—	Dec 31
Form 4	5.63%	906.00	$16.50	$14.95K	Jul 02, 2010	17.00K	Acquisition	—	Jun 30
Form 4	674.48%	87.50K	—	—	May 18, 2010	100.47K	Options	—	May 14 - May 15
Form 4	-18.88%	-10.00K	$17.17	-$136.30K	Apr 20, 2010	42.97K	Sale	—	Apr 16
Form 4	3.40%	426.00	$22.54	$9.60K	Apr 01, 2010	12.97K	Acquisition	—	Mar 31
Form 4	1.96%	241.00	$15.10	$3.64K	Jan 04, 2010	12.55K	Acquisition	—	Dec 31
Form 4	7.20%	827.00	$15.58	$12.89K	Jul 02, 2009	12.31K	Acquisition	—	Jun 30
Form 4	—	75.00K	—	—	May 19, 2009	75.00K	Grant	—	May 15
Form 4	6.24%	674.00	$16.36	$11.03K	Apr 02, 2009	11.48K	Acquisition	—	Mar 31
Form 4	4.74%	489.00	$15.54	$7.60K	Jan 05, 2009	10.81K	Acquisition	—	Dec 31
Form 4	-7.95%	-4.35K	$14.26	-$112.96K	Dec 03, 2008	50.32K	Sale	—	Dec 02
Form 4	-8.92%	-5.35K	$14.26	-$139.04K	Nov 12, 2008	54.66K	Sale	—	Nov 10
Form 4	-0.50%	-300.00	$14.26	-$7.79K	Nov 10, 2008	60.02K	Sale	—	Nov 07
Form 4	-14.22%	-10.00K	$13.45	-$227.19K	Nov 03, 2008	60.32K	Sale	—	Oct 30
Form 4	9.15%	865.00	$15.41	$13.33K	Jul 01, 2008	10.32K	Acquisition	—	Jun 30
Form 4	5.46%	489.00	$18.42	$9.01K	Apr 02, 2008	9.45K	Acquisition	—	Mar 31
Form 4	—	40.00K	—	—	Feb 19, 2008	40.00K	Grant	—	Feb 15
Form 4	5.93%	502.00	$17.14	$8.61K	Jan 07, 2008	8.96K	Acquisition	—	Dec 31
Form 4	0.92%	77.00	$21.13	$1.63K	Oct 02, 2007	8.46K	Acquisition	—	Sep 28
Form 4	—	50.00K	—	—	Sep 18, 2007	50.00K	Grant	—	Sep 14
Form 4	—	25.00K	—	—	Aug 24, 2007	25.00K	Grant	—	Aug 15
Form 4	13.48%	996.00	$15.27	$15.21K	Jul 03, 2007	8.38K	Acquisition	—	Jun 29 - Jul 02
Form 4	3.76%	268.00	$22.07	$5.91K	Apr 03, 2007	7.39K	Acquisition	—	Mar 30
Form 4	—	30.00K	—	—	Feb 16, 2007	30.00K	Grant	—	Feb 15
Form 4	1.17%	82.00	$15.39	$1.26K	Jan 05, 2007	7.12K	Acquisition	—	Jan 03
Form 4	0.85%	59.00	$21.74	$1.28K	Oct 03, 2006	7.04K	Acquisition	—	Sep 29
Form 4	20.08%	1.17K	$18.80	$21.94K	Jul 06, 2006	6.98K	Acquisition	—	Jul 05
Form 4	—	20.00K	—	—	Jun 20, 2006	20.00K	Grant	—	Jun 16
Form 4	-3.13%	-2.00K	$18.63	-$21.50K	May 26, 2006	61.81K	Options	—	May 26
Form 4	4.85%	269.00	$22.97	$6.18K	Apr 10, 2006	5.81K	Acquisition	—	Apr 06
Form 4	4.85%	269.00	$22.97	$6.18K	Apr 10, 2006	5.81K	Acquisition	—	Apr 06
Form 4	—	40.00K	—	—	Feb 02, 2006	40.00K	Grant	—	Jan 31
Form 4	21.56%	904.00	$11.21	$10.14K	Jan 10, 2006	5.10K	Acquisition	—	Jan 03
Form 4	21.56%	904.00	$11.21	$10.14K	Jan 05, 2006	5.10K	Acquisition	—	Jan 03
Form 4	-10.12%	-7.00K	$17.63	-$61.25K	Nov 14, 2005	62.19K	Options	—	Nov 11
Form 4	-6.74%	-5.00K	$16.65	-$34.00K	Nov 02, 2005	69.19K	Options	—	Nov 01
Form 4	-11.88%	-10.00K	$14.63	-$27.50K	Jul 15, 2005	74.19K	Options	—	Jul 14
Form 4	31.81%	1.01K	$9.89	$10.01K	Jul 05, 2005	4.19K	Acquisition	—	Jul 01
Form 4	—	60.00K	—	—	Jun 15, 2005	60.00K	Grant	—	Jun 14
Form 4	—	30.00K	—	—	Feb 15, 2005	30.00K	Grant	—	Feb 14
Form 4	28.06%	697.00	$11.83	$8.25K	Jan 13, 2005	3.18K	Acquisition	—	Jan 11
Form 4	72.62%	1.04K	$9.21	$9.62K	Jan 10, 2005	2.48K	Acquisition	—	Jan 06
Form 4	243.44%	1.02K	$9.44	$9.63K	Jul 26, 2004	1.44K	Acquisition	—	Jun 30
Form 4	—	40.00K	—	—	Jul 02, 2004	40.00K	Grant	—	Jul 01
Form 4	—	419.00	—	—	Jan 13, 2004	419.00	Acq/Dis	—	Jan 12
Form 3/A	—	—	—	—	Sep 17, 2003	—	—	—	—
Form 3	—	—	—	—	Sep 16, 2003	—	—	—	—

Showing 84 results

Third Harmonic Bio, Inc.

Investor

Updated Mar 08, 2023

View Quote Details


Form 4	—	—	—	—	Mar 08, 2023	13.67K	Acq/Dis	—	Mar 06
Form 4	—	13.67K	—	—	Oct 27, 2022	13.67K	Grant	—	Oct 26
Form 3	—	—	—	—	Sep 14, 2022	—	—	—	—

Showing 3 results

EPIX Pharmaceuticals, Inc.

Investor

Updated May 21, 2008


Form 4	—	10.00K	—	—	May 21, 2008	10.00K	Grant	—	May 19
Form 4	—	25.00K	—	—	Jul 02, 2007	25.00K	Grant	—	Jun 27
Form 4	—	5.55K	—	—	Aug 17, 2006	5.56K	Grant	—	Aug 15
Form 3	—	—	—	—	Aug 17, 2006	—	—	—	—

Showing 4 results

Immunocore Holdings plc

Investor

Updated Jan 02, 2024

View Quote Details


Form 3	—	—	—	—	Jan 02, 2024	—	—	—	—

Showing 1 results

Rapport Therapeutics, Inc.

Investor

Updated Nov 07, 2024

View Quote Details


Form 4	—	29.76K	—	—	Nov 07, 2024	29.76K	Grant	—	Nov 07
Form 3	—	—	—	—	Nov 07, 2024	—	—	—	—

Showing 2 results